| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Jingyi Zhang | Q88992227 |
| Wenxia Zong | Q88992229 | ||
| P2093 | author name string | Li Lin | |
| P2860 | cites work | Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction and left ventricular dysfunction: a 24- month follow up study | Q83887142 |
| Stem cell treatment for acute myocardial infarction | Q24186920 | ||
| Bone marrow cells regenerate infarcted myocardium | Q28210640 | ||
| Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) | Q28216990 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction | Q30824170 | ||
| Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data | Q30896351 | ||
| Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial | Q31033745 | ||
| Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial | Q33235180 | ||
| Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis | Q33258314 | ||
| Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. | Q33374961 | ||
| Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenit | Q33413306 | ||
| Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction | Q33440102 | ||
| Intra-coronary bone marrow mononuclear cell transplantation in patients with ST-elevation myocardial infarction: a randomized controlled study | Q33939963 | ||
| Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial | Q34074673 | ||
| Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 | ||
| Long-term effects of bone marrow-derived cells transplantation in patients with acute myocardial infarction: a meta-analysis. | Q34549916 | ||
| Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges | Q34981433 | ||
| Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival | Q35102931 | ||
| Safety and efficacy of intracoronary hypoxia-preconditioned bone marrow mononuclear cell administration for acute myocardial infarction patients: The CHINA-AMI randomized controlled trial | Q35574281 | ||
| Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure | Q35700422 | ||
| Timing for intracoronary administration of bone marrow mononuclear cells after acute ST-elevation myocardial infarction: a pilot study | Q35875311 | ||
| Discrepancy between short-term and long-term effects of bone marrow-derived cell therapy in acute myocardial infarction: a systematic review and meta-analysis | Q36169861 | ||
| Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up | Q37305343 | ||
| The advancing field of cell-based therapy: insights and lessons from clinical trials. | Q37328786 | ||
| Surrogate markers in clinical trials--challenges and opportunities | Q37425499 | ||
| Impact of timing on efficacy and safetyof intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials | Q37580861 | ||
| Short-Term Effect of Autologous Bone Marrow Stem Cells to Treat Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Clinical Trials | Q38466418 | ||
| Cardiac Cell Therapies for the Treatment of Acute Myocardial Infarction: A Meta-Analysis from Mouse Studies. | Q38768753 | ||
| Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials | Q39222871 | ||
| Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction | Q43720251 | ||
| Intracoronary infusion of mononuclear bone marrow-derived stem cells is associated with a lower plaque burden after four years | Q44976551 | ||
| Myocardial blood flow and infarct size after CD133+ cell injection in large myocardial infarction with good recanalization and poor reperfusion: results from a randomized controlled trial | Q47388203 | ||
| Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year | Q50695217 | ||
| Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study). | Q53316434 | ||
| Comparison of Different Bone Marrow-Derived Stem Cell Approaches in Reperfused STEMI. A Multicenter, Prospective, Randomized, Open-Labeled TECAM Trial. | Q53477149 | ||
| Images in cardiovascular medicine. Early tissue distribution of bone marrow mononuclear cells after transcoronary transplantation in a patient with acute myocardial infarction. | Q53576249 | ||
| Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial | Q56610959 | ||
| Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled | Q59260969 | ||
| Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Int | Q61942700 | ||
| Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats | Q74477478 | ||
| Autologous bone-marrow stem-cell transplantation for myocardial regeneration | Q78761519 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P921 | main subject | randomized controlled trial | Q1436668 |
| P304 | page(s) | 611-623 | |
| P577 | publication date | 2018-07-01 | |
| P1433 | published in | Yonsei Medical Journal | Q8055114 |
| P1476 | title | Bone Marrow Mononuclear Cells Transfer for Patients after ST-Elevated Myocardial Infarction: A Meta-Analysis of Randomized Control Trials | |
| P478 | volume | 59 |
| Q64271182 | Safety and efficacy of bone marrow-derived cells therapy on cardiomyopathy: a meta-analysis | cites work | P2860 |
Search more.